ArticleFrontiers in immunology2022

Case Report: Preemptive Treatment With Low-Dose PD-1 Blockade and Azacitidine for Molecular Relapsed Acute Myeloid Leukemia With RUNX1-RUNX1T1 After Allogeneic Hematopoietic Stem Cell Transplantation.

Yutong Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.